Protagenic Therapeutics, Inc.\new Income (Loss) from Equity Method Investments
Protagenic Therapeutics, Inc.\new (PTIX) reported Income (Loss) from Equity Method Investments of -$9.00 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2011-11-14
- Protagenic Therapeutics, Inc.\new income (loss) from equity method investments for the quarter ending 2011-09-30 was -$9.00K.
- Protagenic Therapeutics, Inc.\new income (loss) from equity method investments for the quarter ending 2011-06-30 was $67.00K, a 34.00% increase year-over-year.
- Protagenic Therapeutics, Inc.\new income (loss) from equity method investments for the quarter ending 2010-09-30 was -$13.00K.
- Protagenic Therapeutics, Inc.\new income (loss) from equity method investments for the quarter ending 2010-06-30 was $50.00K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month |
|---|---|---|---|
| 2011-09-30 | -$9.00K 10-Q · filed 2011-11-14 | $58.00K derived: sum of 2 quarters · filed 2011-11-14 | $47.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $67.00K 10-Q/A · filed 2011-09-07 | $56.00K 10-Q/A · filed 2011-09-07 | |
| 2010-09-30 | -$13.00K 10-Q · filed 2011-11-14 | $37.00K derived: sum of 2 quarters · filed 2011-11-14 | -$74.00K 10-Q · filed 2011-11-14 |
| 2010-06-30 | $50.00K 10-Q/A · filed 2011-09-07 | -$60.00K 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |